The loss of enzymes responsible for BCAAs utilization, Bcat1 and Bcat2, impairs NSCLC tumor formation, although these enzymes are not essential for PDAC tumor formation (Li et al., 2020). Here, BCAT2 is linked to non-small cell lung carcinoma.